Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
There are multiple ongoing phase III studies to investigate survodutide for treatment of obesity, diabetes, cardiovascular disease, and chronic kidney disease
Zepbound, Wegovy, and Saxenda are the only GLP-1s FDA-approved specifically for weight loss, but medications like Ozempic and Mounjaro are FDA-approved for diabetes treatment and may be prescribed off-label for weight loss if deemed appropriate by your provider
doi: 10.3389/fendo.2021.721135 [DOI] [PMC free article] [PubMed] [Google Scholar] 59.Lincoff AM, Brown-Frandsen K, Colhoun HM, et al
Moderate obesity, with a BMI of 30 to 35, can reduce life expectancy by three years
And, thats what GLP-1 drugs are: a type of peptide hormone that can stimulate the pancreas to produce more insulin after meals, as well as slow the movement of food from the stomach into the small intestine to help suppress appetite
US$ 27.29
US$ 23.15
US$ 26.98
US$ 28.09
US$ 22.63
US$ 26.43
US$ 23.03
US$ 22.89
